Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRKR Marker Therapeutics > Detailed Quotes

MRKR Marker Therapeutics

0.395
-0.006-1.50%
Close 10/05 16:00 ET
High
0.400
Open
0.398
Turnover
20.96K
Low
0.390
Pre Close
0.401
Volume
52.74K
Market Cap
33.02M
P/E(TTM)
Loss
52wk High
1.690
Shares
83.60M
P/E(Static)
Loss
52wk Low
0.250
Float Cap
23.61M
Bid/Ask %
38.46%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.57
Historical Low
0.074
Dividend TTM
--
Div Yield TTM
--
P/B
1.18
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.09%
Amplitude
2.52%
Avg Price
0.397
Lot Size
1
Float Cap
23.61M
Bid/Ask %
38.46%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.57
Historical Low
0.074
Dividend TTM
--
P/B
1.18
Dividend LFY
--
Turnover Ratio
0.09%
Amplitude
2.52%
Avg Price
0.397
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...